4//SEC Filing
Javitt Daniel C. 4
Accession 0000880984-22-000017
CIK 0001719406other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 7:29 PM ET
Size
6.6 KB
Accession
0000880984-22-000017
Insider Transaction Report
Form 4
Javitt Daniel C.
10% Owner
Transactions
- Sale
common stock
2022-11-30$1.50/sh−8,441$12,700→ 9,634,793 total(indirect: By LLC) - Sale
common stock
2022-11-29$1.50/sh−13,730$20,651→ 9,643,234 total(indirect: By LLC)
Footnotes (2)
- [F1]Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022.
- [F2]Held by Glytech LLC of which the Reporting Person is the sole owner.
Documents
Issuer
NRX Pharmaceuticals, Inc.
CIK 0001719406
Entity typeother
Related Parties
1- filerCIK 0001864534
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 7:29 PM ET
- Size
- 6.6 KB